Xenoestrogens significantly enhance risk for breast cancer during growth and adolescence

Medical Hypotheses

Volumn 50, Issue 6, 1998, Pages 457-464

  Ardies, C M ^a   Dees, C ^b  

^a NORTHEASTERN ILLINOIS UNIVERSITY   (United States)

^b PhotoGen LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYLATED HYDROXYANISOLE; CHLORPHENOTANE; ERYTHROSINE; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; PHTHALIC ACID; THIAZINE DERIVATIVE; XENOBIOTIC AGENT;

ADOLESCENT; ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CHILD; CHILD GROWTH; HUMAN; PRIORITY JOURNAL;

EID: 0031802317     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90262-6     Document Type: Article

References (44)

1. Anonymous. Morb Mortal Wkly Rep 1992; 41: 454.
2. Marshall E. Search for a killer: focus shifts from fat to hormones. Science 1993; 259: 618-621.
3. Elixhauser A. Costs of breast cancer and the cost-effectiveness of breast cancer screening. Int J Technol Assess Health Care 1991; 7: 604-615.
4. Pelehach L. Scientists isolate breast and ovarian cancer gene. Lab Med 1994; 25: 11.
5. Desailly E, Dodin S, Verreault R et al. High organochlorine body burden in women with estrogen receptor positive breast cancer. J Natl Cancer Inst 1994; 86: 232-234.
6. Krieger N, Wolff S S A, Hiatt R A, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines - a prospective study among white, black, and asian women. J Natl Cancer Inst 1994; 86: 589-599.
7. Anderson L F. DDT and breast cancer: the verdict isn't in. J Natl Cancer Inst 1994; 86: 76-77.
8. Stone R. Environmental estrogens stir up debate. Science 1994; 265: 308-310.
9. Davis D L, Bradlow H L, Wolff M, Woodruff T, Hoel D G, Anto-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 1993; 101: 372-377.
10. Harris J R, Lippman M E, Veronesi U, Willet W. Breast cancer. N Engl J Med 1992; 327: 319-328.
11. Willet W C. What should we eat? Science 1994; 532-537.
12. Rose D P, Boyar A P, Wynder E L. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 1986; 58: 2363-2371.
13. Hunter D J, Willett W C. Diet, body size, and breast cancer. Epidemiol Rev 1993; 15: 110-132.
14. Albanes D, Blair A, Taylor P R. Physical activity and risk for cancer in the NHANES I population. Am J Pub Health 1989; 79: 744-750.
15. Frisch R E, Wyshak G, Albright N L et al. Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletes. Br J Cancer 1985; 52: 885-891.
16. Staszewski J. Age at menarche and breast cancer. J Natl Cancer Inst 1971; 47: 935-940.
17. Hirohata T, Shigematsu T, Nomura A M Y, Nomura Y, Harie A, Hirohata I. Occurrence of breast cancer in relation to diet and reproductive history: a case-control study in Fukuoka, Japan. Natl Cancer Inst Monogr 1985; 69: 187-190.
18. Pike M C. Age-related factors in cancers of the breast, ovary, and endometrium. J Chron Dis 1987; 40(suppl. 2): 59s-69s.
19. Russo J, Gusterson B A, Rogers A E, Russo I H, Wellings S E, van Zwieten M J. Biology of disease: comparative study of human and rat mammary tumorogenesis. Lab Invest 1990; 62: 244-278.
20. Ames B N, Shigenaga M K, Hagen T M. Oxidants, anti-oxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90: 7915-7922.
21. Ames B N, Shigenaga M N, Gold L S. DNA lesions, inducible DNA repair, and cell divisions: three key factors in mutagenesis and carcinogenesis. Environ Health Perspect 1993; 101 (suppl. 5): 35-44.
22. Cohen S M, Ellwein L B. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res 1991; 51: 6493-6505.
23. Cohen S. Human relevance of animal carcinogenicity studies. Regul Toxicol Pharmacol 1995; 21: 75-80.
24. Preston-Martin S, Pike M C, Ross R K, Jones P A, Henderson B E, Increased cell division as a cause of human cancer. Cancer Res 1995; 50: 7415-7421.
25. Kato S, Endoh H, Masuhire Y et al. Activation of the estrogen-receptor through phosphorylation by mitogen-activated protein-kinase. Science 1995; 270: 1491-1494.
26. Bunone G, Briand P A, Miksicek R J, Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996; 15: 2174-2183.
27. Jobling S, Reynolds T, White R, Parker M G, Sumpter J P. A variety of environmentally persistent chemicals, including some phthalate plasticizers are weakly estrogenic. Environ Health Perspect 1995; 103: 582-586.
28. Berthois Y, Katzenellenbogen J A, Katzenellenbogen B S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 1986; 83: 2496-2500.
29. 3H] estradiol to the rat uterine receptor. Chem Pharmacol 1974; 23: 451-454.
30. Dees C, Askari M, Garrett S, Gehrs K, Henley D, Ardies C M. A role for the synthetic food colorant Red No. 3 in human breast cancer. Environ Health Perspect; in press.
31. Safe S H. Do environmental estrogens play a role in development of breast cancer in women and male reproductive problems. Hum Ecol Risk Assess 1995; 1: 17-23.
32. vom Saal F S. Environmental estrogenic chemicals: their impact on embryonic development. Hum Ecol Risk Assess 1995; 1: 1-15.
33. Soto A M, Chung K L, Sonenschein C. The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect 1992; 102: 380-383.
34. von Saal F S, Nagel S C, Palanza P, Boechler M, Parmigiani S, Welshaw W V. Estrogenic pesticides: binding relative to estradiol in MCF-7 cells and effects of exposure during fetal life on subsequent behavior in male mice. Toxicol Lett 1995; 77: 343-350.
35. Foster J S, Wimalasena J. Estrogen and antiestrogen regulate cyclin dependent kinase 2 (Cdk2) activity and retinoblastoma protein phosphorylation in MCF-7 breast cancer cells. Mol Endocrinol 1996; 10: 488-498.
36. Dees C, Askari M, Travis C, Foster J S, Wimalasena J. DDT stimulates human breast cancer cells to enter the cell cycle. Unpublished data, under review.
37. Dees C, Travis C, Foster J S, Ahamed S, Wimalasena J. Dietary estrogens stimulate human breast cancer cells to enter the cell cycle. Environ Health Perspect; in press.
38. Dees C, Garrett S, Travis C. The effects of estradiol, xenoestrogens and EMF on human breast cancer cells. Rad Res; in press.
39. Joel P B, Triash H M, Launigan D A. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol Endocrinol 1995; 9: 1041-1052.
40. NAS/NRC. The 1977 Survey of Industry on the Use of Food Additives: Estimates of Daily Intake, Vol. 3. Washington, DC: National Academy of Science / National Research Council, National Academy Press, 1979.
41. Thayer A M. Use of specialty food additives continues to grow. Chem Eng News 1991; June 3: 9-12.
42. Arnold S F, Klotz D M, Collins B M, Vonier P M, Guillette L J, McLachlan J A. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 1996; 272: 1489-1492.
43. Hilakivi-Clarke L, Cho E, Raygada M, Clarke R. How early estrogenic activity affects mammary gland development to increase breast cancer risk. Proc 86th Annu Mtg Am Assoc Cancer Res 1995; 36: 261.
44. Nelson K G, Saki Y, Eitzman B, Steed T, McClachlan J. Exposure to diethylsilbesterol during a critical development period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth Differen 1994; 5: 595-606.